Cohen, SH, Gerding, DN, Johnson, S, et al.
Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol
Kwok, CS, Arthur, AK, Anibueze, CI, Singh, S, Cavallazzi, R, Loke, YK. Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis. Am J Gastroenterol
Garey, KW, Sethi, S, Yadav, Y, DuPont, HL. Meta-analysis to assess risk factors for recurrent Clostridium difficile infection. J Hosp Infect
Miller, BA, Chen, LF, Sexton, DJ, Anderson, DJ. Comparison of the burdens of hospital-onset, healthcare facility-associated Clostridium difficile infection and of healthcare-associated infection due to methicillin-resistant Staphylococcus aureus in community hospitals. Infect Control Hosp Epidemiol
van Nood, E, Vrieze, A, Nieuwdorp, M, et al.
Duodenal infusion of donor feces for recurrent Clostridium difficile
. N Engl J Med
You, DM, Franzos, MA, Holman, RR
Successful treatment of fulminant Clostridium difficile infection with fecal bacterio-therapy. Ann Intern Med
Petrof, EO, Gloor, GB, Vanner, SJ, Weese, SJ. Stool substitute transplant therapy for the eradication of Clostridium difficile infection: “RePOOPulating” the gut. Microbiome
Guidance for industry: enforcement policy regarding investigational new drug requirements for use of fecal microbiota for transplantation to treat Clostridium difficile infection not responsive to standard therapies. US Food and Drug Administration. Federal Register
Anderson, DJ, Miller, BA, Chen, LF, et al.
The network approach for prevention of healthcare-associated infections: long-term effect of participation in the Duke Infection Control Outreach Network. Infect Control Hosp Epidemiol
McDonald, LC, Coignard, B, Dubberke, E, et al.
Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol
Weber, D, Rutala, W, Miller, M, Huslage, K. Role of hospital surfaces in the transmission of emerging health care-associated pathogens: norovirus, Clostridium difficile, and Acinetobacter species. Am J Infect Control
Rupnik, M, Wilcox, MH, Gerding, DN.
Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol
Owens, RC, Donskey, CJ, Gaynes, RP, Loo, VG, Muto, CA. Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis
Moehring, RW, Lofgren, ET,Anderson, DJ. Impact of change to molecular testing for Clostridium difficile infection on healthcare facility-associated incidence rates. Infect Control Hosp Epidemol
Kane, RL, Shamliyan, TA, Mueller, C, Duval, S, Wilt, TJ. The association of registered nurse staffing levels and patient outcomes: systematic review and meta-analysis. Med Care
Ward, NS, Read, R, Afessa, B, Kahn, JM. Perceived effects of attending physician workload in academic medical intensive care units: a national survey of training program directors. Crit Care Med
Thompson, DR, Hamilton, DK, Cadenhead, CD, et al.
Guidelines for intensive care unit design. Crit Care Med
Gillespie, DT. Exact stochastic simulation of coupled chemical reactions. J Phys Chem
Chen, LF, Carriker, C, Staheli, R, et al.
Observing and improving hand hygiene compliance: implementation and refinement of an electronic-assisted direct-observer hand hygiene audit program. Infect Control Hosp Epidemiol
Oughton, MT, Loo, VG, Dendukuri, N, Fenn, S, Libman, MD. Hand hygiene with soap and water is superior to alcohol rub and antiseptic wipes for removal of Clostridium difficile
. Infect Control Hosp Epidemiol
Jabbar, U, Leischner, J, Kasper, D, et al.
Effectiveness of alcohol-based hand rubs for removal of Clostridium difficile spores from hands. Infect Control Hosp Epidemiol
Ballermann, MA, Shaw, NT, Mayes, DC, Gibney, RTN, Westbrook, JI. Validation of the Work Observation Method By Activity Timing (WOMBAT) method of conducting time-motion observations in critical care settings: an observational study. BMC Med Inform Oeds Mak
Riggs, MM, Sethi, AK, Zabarsky, TF, Eckstein, EC, Jump, RLP, Donskey, CJ. Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. Clin Infect Dis
Guerrero, DM, Nerandzic, MM, Jury, LA, Jinno, S, Chang, S, Dons-key, CJ. Acquisition of spores on gloved hands after contact with the skin of patients with Clostridium difficile infection and with environmental surfaces in their rooms. Am J Infect Control
Bobulsky, GS, Al-Nassir, WN, Riggs, MM, Sethi, AK, Donskey, CJ.
Clostridium difficile skin contamination in patients with C. difficile-associated disease. Clin Infect Dis
Sethi, AK, Al-Nassir, WN, Nerandzic, MM, Bobulsky, GS, Donskey, CJ. Persistence of skin contamination and environmental shedding of Clostridium difficile during and after treatment of C. difficile infection. Infect Control Hosp Epidemiol
Lanzas, C, Dubberke, ER, Lu, Z, Reske, KA, Grohn, YT. Epidemiological model for Clostridium difficile transmission in healthcare settings. Infect Control Hosp Epidemiol
Pépin, J, Saheb, N, Coulombe, MA. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis
Mandeli, LA, Wunderink, RG, Anzueto, A, et al.
Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis
Warren, JW, Abrutyn, E, Hebel, JR, Johnson, JR, Schaeffer, AJ, Stamm, WE. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis
Giordano, P, Weber, K, Gesin, G, Kubert, J. Skin and skin structure infections: treatment with newer generation fluoroquinolones. Ther Clin Risk Manag
Vanderhoff, BT, Tahboub, RM. Proton pump inhibitors: an update. Am Fam Physician